Dissecting rare gliomas

Harvard, Mass General researchers ID cells, targets driving rare pediatric glioma

In an April Science study, researchers from Massachusetts General Hospital and Harvard Medical School identified a subpopulation of malignant cells driving disease progression in rare pediatric gliomas with mutated histone H3 K27M using single-cell RNA sequencing analysis, thereby revealing novel pathways that could be targeted to treat the disease.

Read the full 498 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE